STOCK TITAN

Hims & Hers Health (NYSE: HIMS) insider details RSU vesting and share withholding

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Hims & Hers Health, Inc. officer Irene Becklund reported equity transactions dated 12/15/2025. She acquired 17,986 shares of Class A Common Stock through the vesting and settlement of restricted stock units, and 8,867 shares of Class A Common Stock were withheld by the issuer at $36.25 per share to cover tax withholding obligations. After these transactions she directly owned 10,537 shares of Class A Common Stock.

The report also lists multiple restricted stock unit (RSU) awards, each representing a contingent right to receive one share of Class A Common Stock for each RSU. These RSUs are subject to service-based vesting over four-year periods, generally in substantially equal quarterly installments on March 15, June 15, September 15 and December 15, with initial vesting dates beginning on various company quarterly vesting dates from 06/15/2022 through 06/15/2025.

Positive

  • None.

Negative

  • None.
Insider Becklund Irene
Role PAO
Type Security Shares Price Value
Exercise Restricted Stock Unit 1,871 $0.00 --
Exercise Restricted Stock Unit 4,019 $0.00 --
Exercise Restricted Stock Unit 2,291 $0.00 --
Exercise Restricted Stock Unit 4,066 $0.00 --
Exercise Restricted Stock Unit 4,345 $0.00 --
Exercise Restricted Stock Unit 1,394 $0.00 --
Exercise Class A Common Stock 17,986 $0.00 --
Tax Withholding Class A Common Stock 8,867 $36.25 $321K
Holdings After Transaction: Restricted Stock Unit — 1,872 shares (Direct); Class A Common Stock — 19,404 shares (Direct)
Footnotes (1)
  1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. The RSUs are subject to a service-based vesting requirement, which shall be satisfied vest over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after June 15, 2022. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), beginning September 15, 2022. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Becklund Irene

(Last) (First) (Middle)
2269 CHESTNUT STREET, #523

(Street)
SAN FRANCISCO CA 94123

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
PAO
3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 12/15/2025 M 17,986 A (1) 19,404 D
Class A Common Stock 12/15/2025 F 8,867(2) D $36.25 10,537 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit (1) 12/15/2025 M 1,871 (3) (3) Class A Common Stock 1,871 $0 1,872 D
Restricted Stock Unit (1) 12/15/2025 M 4,019 (3) (3) Class A Common Stock 4,019 $0 4,020 D
Restricted Stock Unit (1) 12/15/2025 M 2,291 (4) (4) Class A Common Stock 2,291 $0 4,582 D
Restricted Stock Unit (1) 12/15/2025 M 4,066 (5) (5) Class A Common Stock 4,066 $0 20,331 D
Restricted Stock Unit (1) 12/15/2025 M 4,345 (6) (6) Class A Common Stock 4,345 $0 39,104 D
Restricted Stock Unit (1) 12/15/2025 M 1,394 (7) (7) Class A Common Stock 1,394 $0 18,106 D
Explanation of Responses:
1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
2. The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.
3. The RSUs are subject to a service-based vesting requirement, which shall be satisfied vest over a four-year period, with 6.25% of the RSUs vesting on each Company Quarterly Vesting Date occurring on or after June 15, 2022.
4. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), beginning September 15, 2022.
5. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.
6. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.
7. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2025.
Remarks:
/s/ Kimberly Mather, Attorney-in-Fact for Irene Becklund 12/16/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Hims & Hers Health (HIMS) report in this filing?

An officer of Hims & Hers Health, Inc. reported vesting and settlement of restricted stock units into Class A Common Stock on 12/15/2025, along with shares withheld to satisfy tax obligations.

How many Hims & Hers Health (HIMS) shares were acquired through RSU vesting?

The officer acquired 17,986 shares of Class A Common Stock as a result of the vesting and settlement of restricted stock units reported on 12/15/2025.

How many HIMS shares were withheld for taxes and at what price?

8,867 shares of Hims & Hers Health Class A Common Stock were withheld by the issuer to cover tax withholding obligations at a price of $36.25 per share.

What is the officers direct ownership in Hims & Hers Health (HIMS) after these transactions?

Following the reported transactions, the officer directly owned 10,537 shares of Hims & Hers Health Class A Common Stock.

What type of equity awards are involved and how do HIMS RSUs vest?

The transactions involve restricted stock units (RSUs), each representing a contingent right to receive one share of Class A Common Stock. The RSUs are subject to service-based vesting over four-year periods, generally vesting in substantially equal quarterly installments on March 15, June 15, September 15 and December 15, with different awards beginning to vest between 06/15/2022 and 06/15/2025.

What does each Hims & Hers Health (HIMS) RSU represent in this report?

Each restricted stock unit reported represents a contingent right to receive one share of Hims & Hers Health Class A Common Stock upon satisfaction of the applicable vesting conditions.